Abstract:
The present inven on provides a system and method for building and op mizing biose create a mulayered bio-sensing system by incorpora ng two different formats comprise single wall carbon tubular sensing element and ii) a non-tubular graphene sensing eler mul -layered system allows for assaying molecules across a large range of molecular w sensing molecules in both gas and liquid from a common sample simultanegiffiliyl. By co analyzing both larger, heavier molecules, including, but not limited to: proteins hormon acids, lipids, lipoproteins, etc., with non-tubular graphene sensors and smaller, lighter organic compounds (VOCs) as emi'ed in gas form from the same sample are assayed w walled-carbon nanotubules (SWNTs), this inven on provides a more complete, holis understanding of the organism's current state of health.
Abstract:
The present invention provides an improved system, device, and method for determining a comprehensive state of health in real time using non-invasive patient testing. The invention characterizes disease and other states of health by simultaneously assaying both liquid and gas in a sample or samples. During metabolism, the body performs a large variety of biochemical reactions. Reaction products, reaction by-products, and breakdown products are transported by the circulatory system throughout the body. Many of these molecular products are labile and volatilize into gases from bodily liquids. In gas form, these compounds appear as volatile organic compounds (VOCs).
Abstract:
A drone traffic management system comprising a computer comprising memory means for storing origin coordinates indicating an origin location of a drone, destination coordinates indicating a destination of the drone, and traffic management factors located between the origin location of the drone and the destination of the drone; and processing means for controlling the flight of a drone. This is accomplished by calculating a flight path for the drone to fly automatically from the origin location to the destination location without manual intervention, sending the flight path to the drone, receiving location data of the drone as it travels from the origin location to the destination, re-calculating the flight path of the drone as a function of the traffic management factors and the location data of the drone, and sending the re-calculated flight path to the drone.
Abstract:
A system and method for operating a reward points accumulation and redemption program wherein a user earns reward points from a plurality of independent reward points issuing entities, with each tracking the user's earned reward points in a user reward point account stored on a multi-function card (such as a frequent flyer account or a credit card loyalty account). The multi-function card is adapted to aggregate some or all of the user's earned reward points from the reward accounts and credit the aggregated points into a single reward exchange account on the multi-function card. The user may then select an item for purchase with the accumulated reward points from the multi-function card. The item is provided to the user in exchange for a subset or all of the reward points from the multi-function card.
Abstract:
Product providers are able to liquidate goods via a 5 transacting entity such as a liquidation broker which acts to exchange a user's reward points for the liquidated goods in a manner that is transparent to both the redeeming user and the product provider. A user selects a product to be liquidated from a product provider and then designates to the transacting entity that reward points, held by a reward account holder in a reward point account on the user's behalf, are to be used towards the purchase of the liquidated product in whole or in part. The transacting entity acts to decrease the number of reward points in the user's reward account, as either 15 designated by the user or by a third party, by the required number of points. The reward account holder conveys consideration to the transacting entity equivalent to the par value of the reward points.
Abstract:
A system and method for implementation of product searches via a search engine over a networked computer system such as the Internet. In particular, a user may execute a search for product offers that are accompanied with reward components (e.g. reward points, rebates, coupons, etc.) and/or those that allow payment in whole or in part with payment components (e.g. reward points, rebates, coupons, etc.).
Abstract:
The present invention provides systems and methods to consolidate bio-samples and feed them into a high-throughput assay and analysis system for evaluating Volatile Organic Compounds (VOCs). The invention provides early stage 1 and 2 identification of cancers and other diseases when cures using conventional therapies are readily available. VOCs are compounds resulting from the metabolic reactions of growing pathogenic microbes and of the body's responses to them. Each disease or condition comes with a unique set of VOC signature patterns allowing for the identification of a specific disease or strain from the earliest state of a disease and of pathogenic infections in pre-symptomatic individuals. This invention is a vast improvement over existing technologies currently in use or in development such as next-generation sequencing which requires capturing RNA or DNA fragments free floating in a patient's bloodstream. As a result VOC analysis can detect cancers many months or even years prior to next-generation sequencing.
Abstract:
The present invention provides a platform, system and devices for testing or screening individuals for symptoms of disease, exposure to chemicals or biohazards. The device may be configured similar to the appearance of familiar airport screening devices, but may be configured for use in a people moving device or a walkway. The present device assays volatile compounds, especially volatile organic compounds (VOCs) emitting from a subject person, group or item. Different VOCs are produced dependent on metabolic changes in response to pathogenic, chemical, or biological stresses. Nanosensor elements within the device provide assessments of multiple VOCs to the platform with its integrated analysis capacities that rapidly compare instant data to a developed database. Each chamber may participate in an interconnected system sharing data for continuous improvement of assay procedures and comparison results.
Abstract:
The present invention provides a device and process that rapidly assesses volatile organic compounds (VOCs) present in a gaseous state by reading gas emitted through a subject's skin into the ambient surroundings. The device delivers rapid high-sensitivity capture, classification and pattern recognition to identify a unique VOC profile derived from that bio-sample. A flexible probe module can be appropriately configured with attachments to collect gases from the air surrounding any person, any area enclosed or proximal to a potential VOC source., and/or in clinical applications, near any skin surface, from zones or areas within or immediate adjacent to a body orifice such as nasal passage, otic canal, mouth, armpit, vagina, urethra, navel, anus, vagina, scalp, torso, palm, foot, etc. The device thus provides a practical screening device for clearing persons of interest, e.g., in a waiting room, planning to enter a room or building, a client seeking a personal meeting, etc., and/or providing a handyman, health care worker, or other service provider, a means of assurance when entering a place of service.
Abstract:
The present invention provides a process and method for the early detection and diagnosis of disease by reading and decoding volatile organic compounds (VOCs) for signatures associated with a specific disease. From its outset, each disease begins producing its own unique set of volatile organic compounds. For many diseases, this early-stage detection may be many months or years before noticeable symptoms. The VOC emissions when analyzed, result in a "signature" that identifies and distinguishes the developing, or at later stages, the developed disease. The device assays non-invasively obtained biosamples in real-time to output a VOC based signature that, when correlated with data in a disease signature library, identifies one or more diseases associated with the sample.